Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease

This publication has 9 references indexed in Scilit:

• The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
• Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity
  Brain Research, 1988
• Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists
  European Journal of Pharmacology, 1987
• Pharmacological study of the cortical-induced excitation of subthalamic nucleus neurons in the rat: Evidence for amino acids as putative neurotransmitters
  Neuroscience, 1987
• Striatal inhomogeneities and basal ganglia function
  Movement Disorders, 1986
• Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: Relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake
  Neuroscience Letters, 1986
• γ‐Aminobutyric Acid and Benzodiazepine Receptor Changes Induced by Unilateral 6‐Hydroxydopamine Lesions of the Medial Forebrain Bundle
  Journal of Neurochemistry, 1985
• Possible Therapeutic Applications of Antagonists of Excitatory Amino acid Neurotransmitters
  Clinical Science, 1985
• Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey
  Brain Research, 1979